Generative Design of New-to-nature Biosynthetic Assembly Lines with Genomic Language Modeling
A preprint used genomic language modelling to design biosynthetic pathways while clinical work pushed new biomarkers.
TL;DR
- A bioRxiv preprint described generative design of new-to-nature biosynthetic assembly lines with genomic language modeling.
- A PubMed study proposed epidermal growth factor-like 7 as a potential non-invasive biomarker for fibrosis and mortality risk in MASLD.
- Another paper assessed phenotypic age metrics for risk stratification of chronic disease burden and all-cause mortality in adults.
A bioRxiv preprint described generative design of new-to-nature biosynthetic assembly lines using genomic language modeling, pointing at model-driven pathway design. [1]
In clinical research, a PubMed study proposed epidermal growth factor-like 7 as a potential non-invasive biomarker for fibrosis and mortality risk in MASLD. [2]
Another paper assessed phenotypic age metrics for risk stratification of chronic disease burden and all-cause mortality in adults. [3]
Why it matters
Language-style models are spreading from text into biology, where they are being applied both to design pathways and to surface the biomarkers that guide prevention.
Editor's note
Preprints and abstracts are not peer-reviewed findings and may change; nothing here is medical advice.